Japan has clear and well-structured regulations for clinical trials. These rules help ensure the safety and effectiveness of new drugs. The government provides guidelines that drug developers must follow. The approval process is efficient, making Japan an attractive location for clinical trials. With a large market and strong regulatory support, Japan offers many benefits for […]
Read More →
Russia has become an increasingly attractive venue for conducting clinical trials for international pharmaceutical companies. Russian clinics and principal investigators have proven to be highly capable of conducting clinical research at a level of quality not less than that of investigators in Western Europe and North America. Clinical trials in Russia Sponsors are considering Russia […]
Read More →
Rosacea is a common chronic inflammatory skin condition that causes redness and visible blood vessels on the face. It may also produce small, red, pus-filled bumps. Rosacea can be mistaken for acne, eczema, or a skin allergy. In the US more than 14 million people are estimated living with Rosacea. What is Rosacea? Rosacea is […]
Read More →
China has brought significant reforms in its regulatory system for pharmaceutical industry and clinical trials. In its continuous drive to improve the system, recently China’s Food and Drug Administration (CFDA) announced a major overhaul of its medical device regulations as well. To the current regulations, China has made significant changes. Summarily, 12 articles were newly […]
Read More →
Foot ulcers refer to a patch of broken-down skin usually on the lower leg or feet. In diabetics, when blood sugar levels are high or fluctuate regularly, skin that would normally heal may not properly repair itself because of nerve damage. therefore start a foot ulcer. It occurs in 15% of people with diabetes and precedes […]
Read More →
Glomerulonephritis (GN) is a serious kidney disorder that can lead to end-stage renal disease (ESRD), serious morbidity, or death. Worldwide, IgA Nephropathy (Berger disease) is the most common cause of GN. IgA nephropathy is an autoimmune disease and is one of the most common kidney diseases, other than those caused by diabetes or high blood pressure. […]
Read More →
China is the largest clinical trial market in Asia and the 5th largest in the world. In recent years there was a remarkable increase in Phase I-III clinical trials. Understandably, there must be something significant happening, which brought this change. The recent changes in policies and regulations in China have brought a lot of cheer from […]
Read More →
The Philippines is a country with a large population and a wide network of hospitals, medical centers, and healthcare professionals, making it a fertile platform for conducting clinical trials. In clinical trials, the Philippines ranks number three in Southeast countries (US NIH) and ranks number eight worldwide (European Medicines Agency reports). Clinical trial statistics in […]
Read More →
Pancreatitis, inflammation of the pancreas, is the leading cause of GI-related hospitalizations in the USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In […]
Read More →
Australia has the world’s best researchers and health professionals, a world-class research infrastructure, and high standards for clinical trial conduct, which leads to quality, increased speed, and high confidence in the results. Note: This article was last updated in Oct 2024. They have quality research facilities, an efficient ethical and regulatory framework, a diverse participant […]
Read More →